Sign in
4/A

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-20-002556

Options or other derivatives

  • EXECUTIVE CHAIRMAN OF BOARD acquired 74,048 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jaksch Frank L Jr · EXECUTIVE CHAIRMAN OF BOARD

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-25 Grant or award : show line 1 in the form Employee Stock Options (right to buy) +74,048 74,048 D
Loading xslF345X03/form4a-11062020_011116.xml…